Gene Silencing (Antisense Oligonucleotides - ASOs)

Type: gene_therapy

Status: Investigational (new trials emerging)

Developer: Roche/Ionis Pharmaceuticals

Breakthrough Summary

No summary available.

Mechanism of Action

Details pending.

Year: 2026